As of today (2024-04-25), the Trailing Annual Dividend Yield of VBI Vaccines is 0.00%.
The historical rank and industry rank for VBI Vaccines's Dividend Yield % or its related term are showing as below:
VBIV's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.625 * Ranked among companies with meaningful Dividend Yield % only.
VBI Vaccines's Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00.
VBI Vaccines's Dividends per Share for the
three
months ended in Dec. 2023 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
VBI Vaccines Dividend Yield % Historical Data
The historical data trend for VBI Vaccines's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of VBI Vaccines's Dividend Yield %
For the Biotechnology subindustry, VBI Vaccines's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VBI Vaccines's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, VBI Vaccines's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where VBI Vaccines's Dividend Yield % falls into.
VBI Vaccines Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of VBI Vaccines's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VBIV has been successfully added to your 